000157337 001__ 157337
000157337 005__ 20240229123135.0
000157337 0247_ $$2doi$$a10.1158/1055-9965.EPI-20-0354
000157337 0247_ $$2pmid$$apmid:32732252
000157337 0247_ $$2ISSN$$a1055-9965
000157337 0247_ $$2ISSN$$a1538-7755
000157337 0247_ $$2altmetric$$aaltmetric:86944507
000157337 037__ $$aDKFZ-2020-01566
000157337 041__ $$aeng
000157337 082__ $$a610
000157337 1001_ $$0P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2$$aTurzanski-Fortner, Renée$$b0$$eFirst author$$udkfz
000157337 245__ $$aOvarian cancer risk factor associations by primary anatomic site: the Ovarian Cancer Cohort Consortium.
000157337 260__ $$aPhiladelphia, Pa.$$bAACR$$c2020
000157337 3367_ $$2DRIVER$$aarticle
000157337 3367_ $$2DataCite$$aOutput Types/Journal article
000157337 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1602662703_15239
000157337 3367_ $$2BibTeX$$aARTICLE
000157337 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000157337 3367_ $$00$$2EndNote$$aJournal Article
000157337 500__ $$a2020 Oct;29(10):2010-2018#EA:C020#
000157337 520__ $$aEpithelial ovarian, fallopian tube, and primary peritoneal cancer have shared developmental pathways. Few studies have prospectively examined heterogeneity in risk factor associations across these three anatomic sites.We identified 3,738 ovarian, 337 peritoneal, and 176 fallopian tube incident cancer cases in 891,731 women from 15 prospective cohorts in the Ovarian Cancer Cohort Consortium. Associations between 18 putative risk factors and risk of ovarian, peritoneal, and fallopian tube cancer, overall and for serous and high-grade serous tumors, were evaluated using competing risks Cox proportional hazards regression. Heterogeneity was assessed by likelihood ratio tests.Most associations did not vary by tumor site (phet≥0.05). Associations between first pregnancy (phet=0.04), tubal ligation (phet=0.01) and early-adult (age 18-21 years) body mass index (BMI) (phet=0.02) and risk differed between ovarian and peritoneal cancers. The association between early adult BMI and risk further differed between peritoneal and fallopian tube cancer (phet=0.03). First pregnancy and tubal ligation were inversely associated with ovarian, but not peritoneal, cancer. Higher early-adult BMI was associated with higher risk of peritoneal, but not ovarian or fallopian tube, cancer. Patterns were generally similar when restricted to serous and high-grade serous cases.Ovarian, fallopian tube, and primary peritoneal cancers appear to have both shared and distinct etiologic pathways, although most risk factors appear to have similar associations by anatomic site.Further studies on the mechanisms underlying the differences in risk profiles may provide insights regarding the developmental origins of tumors arising in the peritoneal cavity and inform prevention efforts.
000157337 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000157337 588__ $$aDataset connected to CrossRef, PubMed,
000157337 7001_ $$aRice, Megan S$$b1
000157337 7001_ $$aKnutsen, Synnove F$$b2
000157337 7001_ $$00000-0001-7761-0622$$aOrlich, Michael J$$b3
000157337 7001_ $$aVisvanathan, Kala$$b4
000157337 7001_ $$aPatel, Alpa V$$b5
000157337 7001_ $$00000-0002-6429-4007$$aGaudet, Mia M$$b6
000157337 7001_ $$00000-0003-4385-2097$$aTjonneland, Anne$$b7
000157337 7001_ $$00000-0002-4557-3772$$aKvaskoff, Marina$$b8
000157337 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b9$$udkfz
000157337 7001_ $$aTrichopoulou, Antonia$$b10
000157337 7001_ $$00000-0001-5438-970X$$aPala, Valeria$$b11
000157337 7001_ $$00000-0002-2360-913X$$aOnland-Moret, N Charlotte$$b12
000157337 7001_ $$00000-0002-0031-4152$$aGram, Inger T$$b13
000157337 7001_ $$aAmiano, Pilar$$b14
000157337 7001_ $$00000-0002-7865-4560$$aIdahl, Annika$$b15
000157337 7001_ $$00000-0003-1938-5038$$aAllen, Naomi E$$b16
000157337 7001_ $$00000-0003-2237-0128$$aWeiderpass, Elisabete$$b17
000157337 7001_ $$00000-0002-8460-3938$$aPoynter, Jenny N$$b18
000157337 7001_ $$00000-0002-2120-2280$$aRobien, Kim$$b19
000157337 7001_ $$00000-0003-4946-9099$$aGiles, Graham G$$b20
000157337 7001_ $$00000-0001-5764-7268$$aMilne, Roger L$$b21
000157337 7001_ $$aSetiawan, V Wendy$$b22
000157337 7001_ $$aMerritt, Melissa A$$b23
000157337 7001_ $$00000-0001-8781-8099$$avan den Brandt, Piet A$$b24
000157337 7001_ $$aZeleniuch-Jacquotte, Anne$$b25
000157337 7001_ $$00000-0002-7775-8085$$aArslan, Alan A$$b26
000157337 7001_ $$00000-0002-1931-1349$$aO'Brien, Katie M$$b27
000157337 7001_ $$00000-0002-6776-0018$$aSandler, Dale P$$b28
000157337 7001_ $$00000-0001-7387-6845$$aWolk, Alicja$$b29
000157337 7001_ $$aHåkansson, Niclas$$b30
000157337 7001_ $$00000-0002-2572-6727$$aHarris, Holly R$$b31
000157337 7001_ $$00000-0002-1539-6090$$aTrabert, Britton$$b32
000157337 7001_ $$aWentzensen, Nicolas$$b33
000157337 7001_ $$00000-0002-6986-7046$$aTworoger, Shelley S$$b34
000157337 7001_ $$00000-0003-3361-7560$$aSchouten, Leo J$$b35
000157337 773__ $$0PERI:(DE-600)2036781-8$$a10.1158/1055-9965.EPI-20-0354$$gp. cebp.0354.2020 -$$n10$$p2010-2018$$tCancer epidemiology, biomarkers & prevention$$v29$$x1538-7755$$y2020
000157337 909CO $$ooai:inrepo02.dkfz.de:157337$$pVDB
000157337 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000157337 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000157337 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000157337 9141_ $$y2020
000157337 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEM BIOMAR : 2018$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-17
000157337 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER EPIDEM BIOMAR : 2018$$d2020-01-17
000157337 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000157337 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000157337 980__ $$ajournal
000157337 980__ $$aVDB
000157337 980__ $$aI:(DE-He78)C020-20160331
000157337 980__ $$aUNRESTRICTED